SJS Investment Consulting’s Centessa Pharmaceuticals CNTA Stock Holding History

SJS Investment Consulting’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22	Closed	-$874	–	2902
2026 Q1	$874	Buy	22 +7	+47%	+$179	﹤0.01%	1528
2025 Q4	$376	Buy	+15	New	+$380	﹤0.01%	1621

SJS Investment Consulting's CNTA Position: Q2 2026 in Review

SJS Investment Consulting sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 22 shares — an estimated $874 sold.

SJS Investment Consulting first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $874 in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

SJS Investment Consulting reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SJS Investment Consulting sold 22 Centessa Pharmaceuticals shares in Q2 2026, an estimated $874.
SJS Investment Consulting first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
SJS Investment Consulting's Centessa Pharmaceuticals position peaked at $874 in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.